Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Bio-Gene Technology Ltd. ( (AU:BGT) ) has issued an announcement.
Bio-Gene Technology Ltd. has provided an update on its two projects supported by A$3.0 million in US Department of Defense grants under the Deployed Warfighter Protection program. The Flavocide wearable device project, designed to protect against mosquitoes, is progressing, with initial trials showing promising results. The Qcide indoor spray project, targeting pests like bed bugs and houseflies, is set to commence in 2026 following recent delays. These programs highlight the company’s focus on addressing the rise of insect-borne diseases with innovative, nature-based solutions for both military and civilian use.
More about Bio-Gene Technology Ltd.
Bio-Gene Technology Limited is an Australian company specializing in the development of bio-insecticides targeting global challenges of insecticide resistance. Their innovative products, derived from natural compounds, aim to control pests with minimal harm to human health and the environment. Applications for their products span crop protection, grain storage, public health, and consumer markets.
Average Trading Volume: 689,792
Technical Sentiment Signal: Sell
Current Market Cap: A$7.02M
See more data about BGT stock on TipRanks’ Stock Analysis page.